IPOs

Private biotech M&A surges amid difficult IPO market
BioPharma Dive
Mon, 07/22/24 - 06:44 pm
M&A
IPOs
Actuate halves upcoming IPO to just $22M, scaling back clinical plans for cancer drug
Fierce Biotech
Mon, 07/22/24 - 11:32 am
Acuate Therapeutics
IPOs
oncology
Artiva prices $167M IPO, riding optimism for autoimmune cell therapy
BioPharma Dive
Fri, 07/19/24 - 11:43 am
Artiva
IPOs
autoimmune disease
​​​​​​​Alumis cuts IPO size, but nets $250M for immune drug work
BioPharma Dive
Fri, 06/28/24 - 11:37 am
Alumis
IPOs
Alumis eyes IPO of over $300M to fund clinical-stage TYK2 pipeline
Fierce Biotech
Mon, 06/24/24 - 10:55 am
Alumis
IPOs
TYK2 inhibitors
ESK-001
Ex-Groupon CEO raises $411 million in IPO for precision medicine data company
Axios
Fri, 06/14/24 - 11:07 am
IPOs
Tempus AI
artificial intelligence
precision medicine
Radiopharma firm Telix abandons Nasdaq listing plans
Pharma Voice
Fri, 06/14/24 - 11:06 am
Telix Pharmaceuticals
radiopharmaceuticals
IPOs
Alumis readies IPO to fund rival drug to Bristol Myers’ Sotyktu
BioPharma Dive
Mon, 06/10/24 - 11:17 am
Alumis
IPOs
funding
Bristol Myers Squibb
Sotyktu
psoriatic arthritis
Third Rock’s Rapport reveals upsized $154M IPO
Fierce Biotech
Fri, 06/7/24 - 11:30 am
Rapport Therapeutics
IPOs
epilepsy
As biotech recovers, venture firms’ preferences appear to shift
BioPharma Dive
Fri, 06/7/24 - 11:26 am
funding
biotech
venture capital
M&A
IPOs
Regenerative cell therapy biotech uses IPO to blast into human trials
Pharma Voice
Wed, 06/5/24 - 11:19 am
FibroBiologics
IPOs
cell therapy
regenerative cell therapy
Radiopharma-focused Telix heats up IPO summer market with $200M offering
Fierce Biotech
Wed, 06/5/24 - 11:13 am
radiopharmaceuticals
IPOs
Telix Pharmaceuticals
Rapport talks up $122M IPO to support proof-of-concept epilepsy trials
Fierce Biotech
Mon, 06/3/24 - 10:32 pm
Rapport Therapeutics
IPOs
epilepsy
Biopharma IPOs From the First Half of 2024
BioSpace
Thu, 05/30/24 - 11:17 am
IPOs
biotewch
CG Oncology
Kyverna Therapeutics
ArriVent Biopharma
Alto Neuroscience
Contineum Therapeutics
Boundless Bio
Fractyl Health
Metagenomi
Telomir
Rapport Therapeutics
Telix Pharmaceuticals
Clinical-stage cancer biotech Actuate latest to eye summer IPO
Fierce Biotech
Tue, 05/28/24 - 10:53 am
Actuate Therapeutics
IPOs
cancer
oncology
J&J-backed startup Rapport files for US IPO
Reuters
Sun, 05/19/24 - 10:41 pm
Rapport Therapeutics
JNJ
IPOs
Aardvark raises $85M to target hunger, not appetite, as it contemplates IPO, pharma deals
San Diego Biotech Networks
Thu, 05/9/24 - 07:37 pm
Aardvark Therapeutics
R&D
weight loss
IPOs
funding
CG follows big IPO with new results for bladder cancer drug
BioPharma Dive
Sun, 05/5/24 - 11:35 pm
CG Oncology
IPOs
bladder cancer
cretostimogene
‘Next wave of IPOs’ will arrive in summer, predicts biotech-focused VC partner
Fierce Biotech
Fri, 05/3/24 - 11:32 am
IPOs
biotech
Medicxi
CS Oncology
Contineum Dials Back Plans with $110M IPO to Fund Neuroinflammatory Trials
BioSpace
Fri, 04/5/24 - 11:32 am
Contineum Therapeutics
IPOs
neuroinflammation

Pages